Public Health Agency of Canada’s Regulatory Stock Review Plan: 2024-2027
The Regulatory Stock Review Plan is a public list and description of reviews of regulations that the Public Health Agency of Canada (PHAC) plans to undertake within a three-year period. The stock review plan is developed through careful consideration and consultation on PHAC regulations to determine whether these continue to meet their objectives and how they can better serve people in Canada. It is intended to give Canadians, including businesses, Indigenous peoples, and trading partners an opportunity to inform the reviews of regulations and to plan for the future. The stock review plan will be adjusted and updated every year to reflect PHAC's regulatory priorities and changes to the operating environment.
The stock review plan identifies a departmental contact for the planned reviews and will be adjusted and updated over time to reflect PHAC's regulatory priorities and changes to the operating environment.
Ongoing Reviews
| Title or Working Title of the Regulation(s) | Regulations to Amend Schedule 1 of the Human Pathogens and Toxins Act |
|---|---|
| Enabling Act(s) | Human Pathogens and Toxins Act |
| Rationale | The proposed regulatory amendment to Schedule 1 of the Human Pathogens and Toxins Act will include an update to the list of toxins requiring regulatory oversight and reflect changes in scientific nomenclature, based on recommendations of the external Advisory Committee on Human Pathogens and Toxins. |
| Narrative | The proposed changes will impact laboratories, manufacturers, importers and retailers who may be required to apply for or adjust a licence based on any changes to toxins they are handling. |
| Date of last review or amendment (Year) | 2019 |
| Targeted start for review (Year) | 2020 |
| Title or Working Title of the Regulation(s) | Amendments to the Human Pathogens and Toxins Regulations |
|---|---|
| Enabling Act(s) | Human Pathogens and Toxins Act |
| Rationale | As part of the Regulatory Impact Analysis Statement, a commitment was made to adhere to the Government's life-cycle approach to regulatory development through evaluation of the effectiveness of the Human Pathogens and Toxins Regulations (HPTR) in meeting its objectives. The evaluation was completed and identified areas for regulatory amendments including enhancements to the security clearance program and opportunities to increase clarity and decrease administrative burden on parties regulated by both PHAC and the Canadian Food Inspection Agency (CFIA). PHAC is currently moving forward with next steps to amend the HPTR accordingly. Proposed amendments will also respond to the Evaluation recommendations as applicable. |
| Narrative | The proposed changes will impact regulated parties such as academia, government, and industry working with human pathogens and toxins. |
| Date of last review or amendment (Year) | 2015 |
| Targeted start for review (Year) | 2020 |
| Title or Working Title of the Regulation(s) | Regulations to Amend the Schedule to the Quarantine Act |
|---|---|
| Enabling Act(s) | Quarantine Act |
| Rationale | The proposed regulatory amendment to the Schedule of the Quarantine Act will update the listing of the current reportable communicable diseases to include a new disease for the purposes of the Act. |
| Narrative | The proposed addition would compel travellers and conveyance operators to report the newly listed disease to designated officers at Canada's ports of entry. |
| Date of last review or amendment (Year) | 2020 |
| Targeted start for review (Year) | 2023 |
Proposed New Reviews
| Title or Working Title of the Regulation(s) | Amendments to the Quarantine Regulations |
|---|---|
| Enabling Act(s) | Quarantine Act |
| Rationale | The proposed regulatory amendments would explore improvements to Quarantine Regulations, including potential alignment with the goals of the International Health Regulations. |
| Narrative | The current Quarantine Regulations do not reflect the scope and realities of modern travel and infection or infestation control. They need to be revisited in light of rapid, worldwide transmission and spread of disease, including risks associated with returning travellers on conveyances and their ancillary services. Proposed amendments may have an impact on numerous stakeholders and will involve extensive consultation. |
| Date of last review or amendment (Year) | 2006 |
| Targeted start for review (Year) | 2023 |
Departmental Contact Information
For additional information on PHAC's Regulatory Stock Review Plan, please contact us at pathogens.pathogenes@phac-aspc.gc.ca.
Page details
- Date modified: